Gene expression profile analysis of genes in rat hippocampus from antidepressant treated rats using DNA microarray

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Lee, Jun Ho ^a   Ko, Eunjung ^a   Kim, Young Eun ^a   Min, Ji Young ^a   Liu, Jian ^a   Kim, Yangseok ^a   Shin, Minkyu ^a   Hong, Moochang ^a   Bae, Hyunsu ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; ANTIDEPRESSANT AGENT; CASPASE 8; CYTOKINE; FLUOXETINE; GAMMA INTERFERON; IMIPRAMINE; ITURELIX; MESSENGER RNA; NELUMBINIS SEMEN EXTRACT; PHENELZINE; PLANT EXTRACT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; HIPPOCAMPUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN METABOLISM; RAT; SIGNAL TRANSDUCTION; THERAPY EFFECT; ANIMAL; DEPRESSION; DRUG EFFECT; GENETIC ASSOCIATION; GENETICS; MALE; METABOLISM; METHODOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HIPPOCAMPUS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78649455284     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-152     Document Type: Article

References (38)

1. Kalman J, Palotas A, Juhasz A, Rimanoczy A, Hugyecz M, Kovacs Z, Galsi G, Szabo Z, Pakaski M, Feher LZ, et al. Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the "neuro-immune" system. Neurochem Res 2005, 30:1429-1438. 10.1007/s11064-005-8513-9, 16341940.
2. Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?. Curr Pharm Des 2004, 10:2463-2475. 10.2174/1381612043383872, 2493295, 15320756.
3. Baamonde A, Dauge V, Ruiz-Gayo M, Fulga IG, Turcaud S, Fournie-Zaluski MC, Roques BP. Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation. Eur J Pharmacol 1992, 216:157-166. 10.1016/0014-2999(92)90356-9, 1327810.
4. Tanay VA, Parent MB, Wong JT, Paslawski T, Martin IL, Baker GB. Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain. Cell Mol Neurobiol 2001, 21:325-339. 10.1023/A:1012697904299, 11775064.
5. Paslawski T, Treit D, Baker GB, George M, Coutts RT. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology (Berl) 1996, 127:19-24. 10.1007/BF02805970, 8880939.
6. Griebel G, Curet O, Perrault G, Sanger DJ. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels. Neuropharmacology 1998, 37:927-935. 10.1016/S0028-3908(98)00077-X, 9776388.
7. Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997, 340:249-258. 10.1016/S0014-2999(97)01393-9, 9537821.
8. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 2005, 96:399-409. 10.1111/j.1742-7843.2005.pto_96696601.x, 15910402.
9. Kang M, Pyun KH, Jang CG, Kim H, Bae H, Shim I. Nelumbinis Semen reverses a decrease in hippocampal 5-HT release induced by chronic mild stress in rats. J Pharm Pharmacol 2005, 57:651-656. 10.1211/0022357056055, 15901354.
10. Jang CG, Kang M, Cho JH, Lee SB, Kim H, Park S, Lee J, Park SK, Hong M, Shin MK, et al. Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom. Arch Pharm Res 2004, 27:1065-1072. 10.1007/BF02975433, 15554266.
11. Kang M, Shin D, Oh JW, Cho C, Lee HJ, Yoon DW, Lee SM, Yun JH, Choi H, Park S, et al. The anti-depressant effect of Nelumbinis semen on rats under chronic mild stress induced depression-like symptoms. Am J Chin Med 2005, 33:205-213. 10.1142/S0192415X05002874, 15974480.
12. Castren E. Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 2004, 4:58-64. 10.1016/j.coph.2003.10.004, 15018840.
13. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 2006, 58:115-134. 10.1124/pr.58.1.7, 16507885.
14. Szuster-Ciesielska A, Tustanowska-Stachura A, Slotwinska M, Marmurowska-Michalowska H, Kandefer-Szerszen M. In vitro immunoregulatory effects of antidepressants in healthy volunteers. Pol J Pharmacol 2003, 55:353-362.
15. Xia Z, DePierre JW, Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 1996, 34:27-37. 10.1016/0162-3109(96)00111-7, 8880223.
16. Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 2008, 473:139-146. 10.1016/j.abb.2008.03.018, 2413418, 18395508.
17. Horwood N. Lymphocyte-derived cytokines in inflammatory arthritis. Autoimmunity 2008, 41:230-238. 10.1080/08916930701694766, 18365837.
18. Townsend-Nicholson A, Baker E, Schofield PR, Sutherland GR. Localization of the adenosine A1 receptor subtype gene (ADORA1) to chromosome 1q32.1. Genomics 1995, 26:423-425. 10.1016/0888-7543(95)80236-F, 7601478.
19. Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, Basheer R, Haas HL, Zilles K, Bauer A. Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study. J Neurosci 2007, 27:2410-2415. 10.1523/JNEUROSCI.5066-06.2007, 17329439.
20. Bots M, Medema JP. Granzymes at a glance. J Cell Sci 2006, 119:5011-5014. 10.1242/jcs.03239, 17158907.
21. Buzza MS, Bird PI. Extracellular granzymes: current perspectives. Biol Chem 2006, 387:827-837. 10.1515/BC.2006.106, 16913832.
22. Hsiao EC, Koniaris LG, Zimmers-Koniaris T, Sebald SM, Huynh TV, Lee SJ. Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 2000, 20:3742-3751. 10.1128/MCB.20.10.3742-3751.2000, 85678, 10779363.
23. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 2005, 23:543-548.
24. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002, 26:1407-1433. 10.1038/sj.ijo.0802142, 12439643.
25. Wai PY, Kuo PC. Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 2008, 27:103-118. 10.1007/s10555-007-9104-9, 18049863.
26. Sanicola M, Hession C, Worley D, Carmillo P, Ehrenfels C, Walus L, Robinson S, Jaworski G, Wei H, Tizard R, et al. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc Natl Acad Sci USA 1997, 94:6238-6243. 10.1073/pnas.94.12.6238, 21033, 9177201.
27. Grondin R, Gash DM. Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease. J Neurol 1998, 245:P35-42. 10.1007/PL00007744, 9808338.
28. Yoong LF, Too HP. Glial cell line-derived neurotrophic factor and neurturin inhibit neurite outgrowth and activate RhoA through GFR alpha 2b, an alternatively spliced isoform of GFR alpha 2. J Neurosci 2007, 27:5603-5614. 10.1523/JNEUROSCI.4552-06.2007, 17522305.
29. Gray PW, Goeddel DV. Structure of the human immune interferon gene. Nature 1982, 298:859-863. 10.1038/298859a0, 6180322.
30. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189. 10.1189/jlb.0603252, 14525967.
31. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2001, 2:492-501. 10.1038/35081564, 11433374.
32. Dhavan R, Tsai LH. A decade of CDK5. Nat Rev Mol Cell Biol 2001, 2:749-759. 10.1038/35096019, 11584302.
33. Monaco EA. Recent evidence regarding a role for Cdk5 dysregulation in Alzheimer's disease. Curr Alzheimer Res 2004, 1:33-38. 10.2174/1567205043480519, 15975083.
34. Maes M, Scharpe S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche BV, Cosyns P. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res 1994, 54:143-160. 10.1016/0165-1781(94)90003-5, 7761549.
35. Smith RS. The macrophage theory of depression. Med Hypotheses 1991, 35:298-306. 10.1016/0306-9877(91)90272-Z, 1943879.
36. Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 1999, 19:10494-10501.
37. Lammers CH, D'Souza UM, Qin ZH, Lee SH, Yajima S, Mouradian MM. Regulation of striatal dopamine receptors by corticosterone: an in vivo and in vitro study. Brain Res Mol Brain Res 1999, 69:281-285. 10.1016/S0169-328X(99)00105-9, 10366749.
38. Le Poul E, Boni C, Hanoun N, Laporte AM, Laaris N, Chauveau J, Hamon M, Lanfumey L. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 2000, 39:110-122. 10.1016/S0028-3908(99)00088-X, 10665824.